Renjing Jin

机构：Peking University, Peking University Third Hospital

发表论文 6 篇 · 总被引 15 次 · h-index 2

代表论文

• EZH2 in non-cancerous diseases: expanding horizons (2025 · Protein & Cell · 被引 5)
• Subsegmentectomy versus segmentectomy resection for the treatment of operable patients with stage IA non-small cell lung cancer: A meta-analysis (2023 · Frontiers in Surgery · 被引 4)
• The Ribonuclease ZC3H12A is required for self-inflicted DNA breaks after DNA damage in small cell lung cancer cells (2024 · Cellular Oncology · 被引 2)
• To cleave or not and how? The DNA exonucleases and endonucleases in immunity (2024 · Genes & Diseases · 被引 2)
• Fenofibrate potentiates the therapeutic efficacy of EZH2 inhibitors on melanoma via TRIM21‐ and OTUD4‐mediated EZH2 ubiquitination (2026 · British Journal of Pharmacology · 被引 1)
• Long-Read Sequencing Annotation of the Transcriptome in DNA-PK Inactivated Cells (2022 · Frontiers in Oncology · 被引 1)